247
Participants
Start Date
December 31, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature
Automatic suspension of insulin delivery when glucose is low.
Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump
No Automatic suspension of insulin delivery when glucose is low.
Naomie Barrie Diabetes Center, New York
Joslin Diabetes Center, Syracuse
Physicians Research Associates, Lawrenceville
Endocrine Research Solutions, Roswell
Atlanta Diabetes Associates, Atlanta
Metabolic Research Institute, West Palm Beach
Ohio University College of Osteopathic Medicine, Athens
Iowa Diabetes and Endocrinology Research Center, Des Moines
University of Wisconsin - Madison, Madison
International Diabetes Center, Minneapolis
Arkansas Diabetes Clinic and Research Center, Little Rock
Texas Diabetes, Austin
University of Colorado Denver/ Barbara Davis Center for Childhood Diabetes, Aurora
Rocky Mountains Diabetes and Osteoporosis Center, Idaho Falls
AMCR Institute, Inc, Escondido
Frank Diabetes Research Institute/ Mills-Peninsula Health Center, San Mateo
Rainier Clinical Research Center, Renton
Medtronic Diabetes
INDUSTRY